Search results

Australian and New Zealand Society of Nuclear Medicine recognises Nigel Lengkeek

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

ANSTO is interested finding students to collaborate on Generation IV reactor systems.

Cosmogenic nuclides measurements at ANSTO to be part of large international Antarctic glacier research.

Research collaboration with University of Sydney focuses on a personalised approach to cancer treatment.

Lutetium-177 used for advanced prostate cancer

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science 

A dedicated team of radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) are behind the successful detection and rapid retrieval of a missing radioactive source in outback Western Australia.

Doping with transition metals produced stability in bismuth oxide.